Ho-Sheng Lee (Ho-Shen Lee)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Emergency Department

Simultaneous Determination

Top Venues

Open forum infectious diseases

Expert review of anti-infective therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Ho-Sheng Lee, Yu-Feng Wei, Chin-Chung Shu
Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis. Biomedicines 11 (12) (2023)
Ho-Sheng Lee, Yu-Feng Wei, Chin-Chung Shu
Influence of Rifamycin on Survival in Patients with Concomitant Lung Cancer and Pulmonary Tuberculosis. Biomedicines 11 (12) (2023)
Chi-Lun Tsai, Chih-Cheng Lai, Ching-Yi Chen, Ho-Sheng Lee
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis. Expert review of anti-infective therapy (2022)
Ho-Sheng Lee, Yu-Feng Wei, Yi-Jung Tsai, Ping-Huai Wang, Chung-Yu Chen, Sheng-Wei Pan, Chin-Chung Shu
Prevalence of Latent Tuberculous Infection in Patients With Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country. Open forum infectious diseases 9 (3) (2022)
Ping-Huai Wang, Ming-Fang Wu, Chi-Yu Hsu, Shu-Yung Lin, Ya-Nan Chang, Ho-Sheng Lee, Yu-Feng Wei, Chin-Chung Shu
The Dynamic Change of Immune Checkpoints and CD14+ Monocytes in Latent Tuberculosis Infection. Biomedicines 9 (10) (2021)